View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AF47 | Publication ID: Fall 2015 |
Title: Use of Materials Derived From Cattle in Human Food and Cosmetics | |
Abstract:
FDA is making permanent interim measures to minimize human exposure to materials that scientific studies have demonstrated are highly likely to contain the bovine spongiform encephalopathy (BSE) agent in cattle infected with the disease. Scientist believe that the human disease variant (vCJD) is likely caused by the consumption of products contaminated with the agent that causes BSE. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 189.5 21 CFR 700.27 | |
Legal Authority: 21 U.S.C. 342 21 U.S.C. 348 21 U.S.C. 361 21 U.S.C. 371 |
Legal Deadline:
None |
|||||||||||||||||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
RIN Data Printed in the FR: No | |
Agency Contact: Johnny Braddy Senior Policy Advisor Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nuturition, HFS-315, 5100 Paint Branch Parkway, College Park, MD 20740 Phone:240 402-1709 Fax:301 436-2632 Email: johnny.braddy@fda.hhs.gov |